Dr. Kimberly E. Stepien, MD

Dr. Stepien practices at University Health Services - Madison (Highland Ave) in Madison, Wisconsin.

Dr. Stepien's NPI, 1497709174, was assigned on May 19, 2006. Dr. Stepien graduated from University of Wisconsin School of Medicine in 2002. Dr. Stepien holds Wisconsin license 50403.

Dr. Stepien's primary practice is University Health Services - Madison (Highland Ave), at 600 Highland Ave, Madison, WI 53792. The practice phone is (608) 265-1978.

Dr. Stepien's primary practice is University Health Services - Madison (Highland Ave) in Madison, Wisconsin. Dr. Stepien is also affiliated with University Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Stepien to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Stepien's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stepien practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Stepien's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Stepien is licensed in Wisconsin.

CMS data shows 2,150 Medicare services from Dr. Stepien across 6 procedure codes in 2024, for 320 Medicare patients. Medicare paid $74,703 for them. Every service was in an office.

CMS counts 320 Medicare patients who saw Dr. Stepien in 2024. The largest group is 65 to 74, with 133 patients. 66% of them have high blood pressure, and 63% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stepien's median patient age at 72, with 59% women.

In 2024, Dr. Stepien wrote 41 Medicare Part D claims for 17 patients. 66% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $51 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Stepien for performance year 2024, reported as part of a group. Dr. Stepien accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 33 papers to Dr. Stepien, published from 2011 to 2024. 2011 was the busiest year, with 3. The most frequent topics are Tomography, Optical Coherence, Ophthalmoscopy and Visual Acuity. Dr. Stepien has published most often in Invest Ophthalmol Vis Sci. Dr. Stepien's most frequent co-authors are Thomas B. Connor, MD, Dennis P. Han, MD and Pooja Godara, MD.

Dmand AI links Dr. Stepien to 2 clinical trials, 2 of them phase 2/3 studies. Conditions studied include Usher Syndromes and Deaf-Blind Disorders. Laboratoires Thea sponsors the most, 2.

CMS Open Payments shows 3 general payments to Dr. Stepien from 3 drug and device companies from 2016 to 2019. Consulting fees make up the largest share, 98% of the total. Spark Therapeutics, Inc. paid the most, $4,433.

Dr. Stepien graduated from University of Wisconsin School of Medicine in 2002.